NOTES
TO UNAUDITED FINANCIAL STATEMENTS
NOTE
1 – ORGANIZATION AND DESCRIPTION OF BUSINESS
C2E
Energy, Inc.(‘the Company”) f/k/as Odyssey Oil & Energy, Inc. was formed in Florida in August 2001 with the plan
of becoming a direct marketing company that developed and marketed premium-quality, premium-priced, branded fitness, and exercise
equipment to the home fitness equipment market. The original business plan included marketing products directly to consumers
through a variety of direct marketing channels.
As
an initial step, the Company licensed the rights to a portable gym subject to patent protection in the United States, which was
eligible to be marketed under the trademark Better Buns. It was the Company’s intention for this product to be
its first direct-marketed product. The Company was unsuccessful in its attempts to raise funding to pursue this goal and in May
2005, received notice that it was in breach of its license agreement for the Better Buns product and that the license was being
terminated. Since inception to date, the Company has not generated any revenues through the sale of the Better Buns
product or otherwise, and has not engaged in any marketing activities due to limited funds and resources.
In
September 2005, the Company changed focus in connection with the Merger of a wholly-owned subsidiary of the Company and CardioBioMedical
Corporation (“CBM”), a Delaware corporation. The subsidiary merged with and into CBM, with CBM as the surviving
corporation which became a subsidiary of the Company. The consideration for the merger consisted of 66,232,527 shares of the Company
common stock, $.0001 par value, payable on a one-for-one basis to the consenting shareholders of CBM and a warrant, exercisable
beginning January 1, 2008, to purchase 19,500,000 shares of the Company common stock at a purchase price of $.003 per share payable
to the sole warrant holder of CBM in exchange for an equivalent CBM warrant.
The
new objective of the Company was to establish a medical device, the Cardio Spectrum Diagnostic System as the standard of care
for the detection of early-stage ischemic heart disease. The Company’s strategy consisted of (i) attempting
to obtain insurance reimbursement for performance of the diagnostic test (ii) establish the device with cardiologists and (iii)
finally gain acceptance and use by other physician specialties and hospitals. The Company was unsuccessful in its attempts to
obtain insurance reimbursement and marketing CSD.
On
April 21, 2006, we began the realization of our new strategy by purchasing a 10% working interest in oil and gas leases in Texas
from Centurion Gold Holdings, Inc., a related public company.
On
November 21, 2007 we entered into a new phase of our strategy by acquiring a Uranium Prospect known as Springbok Flats in the
Bela District of South Africa.
On
January 15, 2008, the Company’s well operator determined that the Leslie 1 Well of BBB Area, Wharton Texas, was no longer
commercially viable and the well was plugged and abandoned.
On
June 16, 2008, the Company acquired ALG Bio Oils Limited, which in turn owns 100% of ALG Western Oils (Pty) Ltd. ALG Western Oils
has the technology to make bio fuel from algae and has entered into a Letter of Intent with Xstrata Alloys to begin a bio fuel
project at the Boshoek smelter in South Africa. The construction of the pilot plant was completed during the quarter ended June
30, 2009 and is undergoing various tests. This acquisition continues the Company’s strategy of investing in energy related
enterprises.
The
Company intended to expand the making of bio fuels from algae to other large mining Companies in South Africa.
On
May 26, 2009, the Company acquired 51% of H-Power (Pty) Ltd. H-Power (Pty) Limited, a South African registered company, which
owns an exclusive license to develop and market batteries based on patented Hybrid Battery Technology worldwide. However, on August
27, 2009, the Company entered into an agreement to cancel the purchase of the 51% of H-Power (Pty) Ltd. H-Power required substantial
capital as well as a partner to develop a production line for the batteries based on its patented Hybrid Battery Technology.
Prior
to February 2021, the Company has been dormant for the approximately the last eight years.
On
February 10, 2021, as a result of a custodianship in Palm Beach, Florida Case Number: 502020CA013695XXXXMB AB, Custodian
Ventures LLC (“Custodian”) was appointed custodian of the Company. David Lazar is the managing member of Custodian.
On
February 10, 2021, the Custodian appointed David Lazar as the Company’s Chief Executive Officer, President, Secretary, Chief
Financial Officer, Chief Executive Officer and Chairman of the Board of Directors.
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”)
“FASB Accounting Standard Codification™” (the “Codification”) which is the source of authoritative
accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements
in conformity with generally accepted accounting principles (“GAAP”) in the United States.
Going
Concern
The
accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following
the date of these financial statements. As of March 31, 2021, the Company had no cash, negative working capital of 34,745
and an accumulated deficit of $70,793,080.
Because
the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this
raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to
raise additional funds and is currently exploring alternative sources of financing. Currently, the Company is being funded by
David Lazar who has extended interest-free demand loans to the Company. There can no assurance that he will continue to fund the
Company.
Management’s
Representation of Interim Financial Statements
The
accompanying unaudited condensed consolidated financial statements have been prepared by the Company without audit pursuant to
the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting
policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included
in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”)
have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate
to make the information presented not misleading. These condensed consolidated financial statements include all of the adjustments,
which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such
adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year.
Use
of Estimates
The
preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect
the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income
taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other
assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements.
The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from these estimates.
Cash
and cash equivalents
The
Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents.
On March 31, 2021, and December 31, 2020, the Company’s cash equivalents totaled $-0- and $-0- respectively.
Income
taxes
The
Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred
tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes” prescribes
a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken
or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be
sustained upon examination by taxing authorities.
The
amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate
settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts
or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability
under audit.
Net
Loss per Share
Net
loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as
defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”)
calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during
the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number
of common shares and dilutive common share equivalents outstanding.
Recent
Accounting Pronouncements
There
are no recent accounting pronouncements that impact the Company’s operations.
NOTE
3 – NOTES PAYABLE-RELATED PARTY
As
of March 31, 2021, and December 31, 2020, the balances of notes payable related party were $28,035 and $5,000, respectively. These
interest free demand loans are being extended by Custodian Ventures, LLC, the Company’s Court appointed custodian.
NOTE
4 – EQUITY
Common
Stock
The
Company has authorized 2,000,000,000 shares of $0.0001 par value, common stock. As of March 31, 2021, and December 31,
2020, there were 1,994,657,080 shares of Common Stock issued and outstanding.
The
Company did not issue any common shares in 2021 or 2020.
Preferred
Stock
The
Company has authorized 20,000,000 shares of Series A Preferred Stock at a par value of $0.0001. As of December 31, 2020, and December
31, 2019, there were -0- shares issued and outstanding. The preferred shares are convertible to common shares at a ratio of 30
to 1.
NOTE
5 – COMMITMENTS AND CONTINGENCIES
The
Company did not have any contractual commitments as of March 31, 2021, and December 31, 2020.
NOTE
6 – SUBSEQUENT EVENTS
In
accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial
statements were available to be issued and has determined that it does not have any material subsequent events to disclose in
these financial statements.